Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Expression of cytochrome P450 in non-small cell lung cancerTsunehiro Oyama, Kenji Sugio, Toyohi Isse, et al.
Clinical Lung Cancer|November 17, 2020
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)Hajime Asahina, Kentaro Tanaka, Satoshi Morita, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2008
Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in JapanYoshika Nagata, Takeshi Hanagiri, Makiko Mizukami, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapyYoshinobu Ichiki, Takeshi Hanagiri, Mitsuhiro Takenoyama, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|April 5, 2023
The efficacy of thoracoscopic surgery for descending necrotizing mediastinitisYugo Tanaka, Yoshimasa Maniwa, Kenji Sugio, et al.
The Journal of Dermatology|March 19, 2016
Pemetrexed-induced scleroderma-like conditions in the lower legs of a patient with non-small cell lung carcinomaKazushi Ishikawa, Takashi Sakai, Tomoko Saito-Shono, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2021
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Hajime Asahina, Junji Kishimoto, et al.
Thoracic Cancer|July 23, 2022
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 studyMinoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2011
Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: a case reportTaro Ohba, Kenji Sugio, Takuro Kometani, et al.
Thoracic Cancer|November 25, 2016
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)Minoru Fukuda, Midori Shimada, Takeshi Kitazaki, et al.
Pageof 19